Metagenomi, Inc. (MGX)
NASDAQ: MGX · Real-Time Price · USD
2.360
-0.080 (-3.28%)
Feb 21, 2025, 4:00 PM EST - Market closed
Metagenomi Employees
Metagenomi had 236 employees as of December 31, 2023.
Employees
236
Change
n/a
Growth
n/a
Revenue / Employee
$233,390
Profits / Employee
-$313,364
Market Cap
88.32M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 236 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
MGX News
- 11 days ago - Metagenomi to Present at TD Cowen's 45th Annual Health Care Conference - GlobeNewsWire
- 5 weeks ago - Metagenomi Highlights Progress Across Therapeutic Portfolio and Outlines Anticipated Milestones - GlobeNewsWire
- 5 weeks ago - Metagenomi Announces New Appointment to its Board of Directors - GlobeNewsWire
- 6 weeks ago - Metagenomi to Present at the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 2 months ago - Metagenomi Presents Highly Specific and Efficient Genome Editing Tools at Nature Conference “RNA at the Bench and Bedside IV” - GlobeNewsWire
- 2 months ago - Metagenomi Presents Updated Preclinical Data in Hemophilia A at American Society of Hematology (ASH) 66th Annual Meeting - GlobeNewsWire
- 3 months ago - Metagenomi, Inc. Is Being Sued For Violating Securities Laws And Shareholders With Losses Are Urged To Contact The Schall Law Firm - Accesswire
- 3 months ago - FINAL DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Metagenomi - Business Wire